About Us

Leadership Team

Leadership Team

Deborah Geraghty, PhD

Chief Business Officer

Deborah Geraghty, PhD

Dr. Geraghty brings 20 years of extensive experience in the life sciences industry, serving in senior strategic, commercial, and portfolio positions. Prior to Anokion, Deb was SVP, corporate strategy at Dimension Therapeutics, where she played a lead role in the company’s Series B financing and initial public offering, and was responsible for driving growth of the company’s portfolio prior to its successful IPO and recent acquisition by Ultragenyx Pharmaceutical Inc. Previous to Dimension, Dr. Geraghty was founder and vice president, project and portfolio development at Cydan Development, an orphan drug accelerator that raised $26 million to identify and de-risk assets with therapeutic and commercial potential. Prior, Dr. Geraghty was head of portfolio advancement at Aileron Therapeutics, where she led strategic growth and commercial efforts, and was director, new product marketing, at Infinity Pharmaceuticals. She also founded Back Bay Strategies, and held multiple positions at Kendall Strategies, Feinstein Kean Healthcare, and Genzyme Corp. Dr. Geraghty serves on the medical and scientific advisory board of Global Genes, a leading rare disease patient advocacy organization. She earned a BS in Biology at Union College, an MBA from the Carroll School at Boston College, and a PhD in Molecular Biology at the University of Vermont.

Back to Leadership Team